146 related articles for article (PubMed ID: 8215292)
1. Antibiotic susceptibility of group A streptococci: a 6-year follow-up study.
Betriu C; Sanchez A; Gomez M; Cruceyra A; Picazo JJ
Antimicrob Agents Chemother; 1993 Aug; 37(8):1717-9. PubMed ID: 8215292
[TBL] [Abstract][Full Text] [Related]
2. [Antibiotic resistance to erythromycin, clindamycin and tetracycline of 573 strains of Streptococcus pyogenes (1992-1994)].
Orden B; Martínez R; López de los Mozos A; Franco A
Enferm Infecc Microbiol Clin; 1996 Feb; 14(2):86-9. PubMed ID: 8714154
[TBL] [Abstract][Full Text] [Related]
3. Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study.
Betriu C; Casado MC; Gómez M; Sanchez A; Palau ML; Picazo JJ
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):255-60. PubMed ID: 10212752
[TBL] [Abstract][Full Text] [Related]
4. [Streptococcus pyogenes: penicillin and erythromycin susceptibility in the cities of Neuquen and Cipolletti].
Soriano SV; Brasili S; Saiz M; Carranza C; Vidal P; Calderón J; Lopardo HA
Medicina (B Aires); 2000; 60(4):487-90. PubMed ID: 11188957
[TBL] [Abstract][Full Text] [Related]
5. Comparative susceptibility of clinical group A, B, C, F, and G beta-hemolytic streptococcal isolates to 24 antimicrobial drugs.
Traub WH; Leonhard B
Chemotherapy; 1997; 43(1):10-20. PubMed ID: 8996736
[TBL] [Abstract][Full Text] [Related]
6. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain.
Perez-Trallero E; Urbieta M; Montes M; Ayestaran I; Marimon JM
Eur J Clin Microbiol Infect Dis; 1998 Jan; 17(1):25-31. PubMed ID: 9512178
[TBL] [Abstract][Full Text] [Related]
7. Erythromycin resistance in group A beta-hemolytic streptococci.
Haddy RI; Gordon RC; Shamiyeh L; Wofford R; Fechner L; Sahanek E
Pediatr Infect Dis; 1982; 1(4):236-8. PubMed ID: 6757890
[TBL] [Abstract][Full Text] [Related]
8. [Susceptibility of Streptococcus pyogenes to macrolides and quinolones in Guadalajara, Spain].
Rodríguez-Zurita ME; Solís del Baño S; Robres Guillén P; González Praetorius A; Gimeno Fernández C; Pérez Pomata MT; Bisquert Santiago J
Rev Esp Quimioter; 2003 Mar; 16(1):61-4. PubMed ID: 12750759
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. Spanish Group for the Study of Infection in the Primary Health Care Setting.
Alós JI; Aracil B; Oteo J; Torres C; Gómez-Garcés JL
J Antimicrob Chemother; 2000 May; 45(5):605-9. PubMed ID: 10797081
[TBL] [Abstract][Full Text] [Related]
10. Emergence of erythromycin-resistant, clindamycin-susceptible Streptococcus pyogenes isolates in Madrid, Spain.
Garcia-Bermejo I; Cacho J; Orden B; Alós JI; Gómez-Garcés JL
Antimicrob Agents Chemother; 1998 Apr; 42(4):989-90. PubMed ID: 9559831
[No Abstract] [Full Text] [Related]
11. The emergence of erythromycin-resistant Streptococcus pyogenes in Seoul, Korea.
Cha S; Lee H; Lee K; Hwang K; Bae S; Lee Y
J Infect Chemother; 2001 Jun; 7(2):81-6. PubMed ID: 11455497
[TBL] [Abstract][Full Text] [Related]
12. Argentinian collaborative study on prevalence of erythromycin and penicillin susceptibility in Streptococcus pyogenes. The Argentinian Streptococcus Study Group.
Lopardo HA; Venuta ME; Vidal P; Rosaenz L; Corthey C; Farinati A; Couto E; Sarachian B; Sparo M; Kaufman S; De Mier CA; Gubbay L; Scilingo V; Villaverde P
Diagn Microbiol Infect Dis; 1997 Sep; 29(1):29-32. PubMed ID: 9350412
[TBL] [Abstract][Full Text] [Related]
13. Serotyping and susceptibility to macrolides and other antimicrobial drugs of Streptococcus pyogenes isolated from patients with invasive diseases in southern Israel.
Weiss I; Gorodnitzky Z; Korenman Z; Yagupsky P
Eur J Clin Microbiol Infect Dis; 1997 Jan; 16(1):20-3. PubMed ID: 9063669
[TBL] [Abstract][Full Text] [Related]
14. Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains in Italy and heterogeneity of inducibly resistant strains.
Giovanetti E; Montanari MP; Mingoia M; Varaldo PE
Antimicrob Agents Chemother; 1999 Aug; 43(8):1935-40. PubMed ID: 10428916
[TBL] [Abstract][Full Text] [Related]
15. Predominance of two M-types among erythromycin-resistant group A Streptococci from Greek children.
Zachariadou L; Papaparaskevas J; Paraskakis I; Efstratiou A; Pangalis A; Legakis NJ; Tassios PT
Clin Microbiol Infect; 2003 Apr; 9(4):310-4. PubMed ID: 12667242
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of erythromycin resistance and resistance phenotypes in group A beta hemolytic streptococci].
Kaya EG; Yücel M; Karakoç AE
Mikrobiyol Bul; 2006 Jul; 40(3):161-8. PubMed ID: 17001844
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada.
De Azavedo JC; Yeung RH; Bast DJ; Duncan CL; Borgia SB; Low DE
Antimicrob Agents Chemother; 1999 Sep; 43(9):2144-7. PubMed ID: 10471555
[TBL] [Abstract][Full Text] [Related]
18. Streptococcus pyogenes isolated in Portugal: macrolide resistance phenotypes and correlation with T types. Portuguese Surveillance Group for the Study of Respiratory Pathogens.
Melo-Cristino J; Fernandes ML
Microb Drug Resist; 1999; 5(3):219-25. PubMed ID: 10566873
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance.
Betriu C; Culebras E; Rodríguez-Avial I; Gómez M; Sánchez BA; Picazo JJ
Antimicrob Agents Chemother; 2004 Jan; 48(1):323-5. PubMed ID: 14693558
[TBL] [Abstract][Full Text] [Related]
20. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.
Sutcliffe J; Tait-Kamradt A; Wondrack L
Antimicrob Agents Chemother; 1996 Aug; 40(8):1817-24. PubMed ID: 8843287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
